CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>
Karlo PericaCellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkNayan JainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New YorkMichael ScordoAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkRuchi PatelMarie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New YorkÖzgür Can ErenHematopathology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New YorkUtsav PatelDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New YorkGunes GundemComputational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New YorkDylan DomenicoComputational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New YorkSneha MitraComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New YorkNicholas D. SocciMarie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New YorkJ.K. EverettDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, PhiladelphiaAoife M. RocheDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, PhiladelphiaAngelina PetrichenkoDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, PhiladelphiaGunjan L. ShahAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkMaria E. ArcilaDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New YorkLaetitia BorsuDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New YorkJae H. ParkCellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkSteven M. HorwitzCellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkSergio GiraltAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkAhmet DoǧanHematopathology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New YorkChristina C. LeslieComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New YorkElli PapaemmanuilComputational Oncology Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New YorkFrederic D. BushmanDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, PhiladelphiaSaad Z. UsmaniAdult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New YorkMichel SadelainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New YorkSham MailankodyCellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
2025en
ABI
Аннотация
, which developed in a patient with multiple myeloma after B-cell maturation antigen (BCMA) CAR T-cell therapy.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0